Molecular Formula | C17H14O5 |
Molar Mass | 298.29 |
Solubility | ethanol: 2.5mg/mL, soluble |
Appearance | crystalline solid or supercooled liquid |
Color | White |
Storage Condition | Sealed in dry,Room Temperature |
Stability | Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 6 months. |
In vitro study | AH 6809 (1 μM; 30 min) inhibits T. serrulatus venom (TsV)-induced and PGE 2 -amplified IL-1β and cAMP production in macrophages. AH 6809 (30-300 μM) antagonizes the anti-aggregatory activity of PGD2 in whole blood, with an apparent pA 2 of 5.35. |
In vivo study | AH 6809 (5 mg/kg; i.p.) decreases TsV-induced mortality, PGE 2 and IL-1β production and neutrophil infiltration in the lungs of mice. |
WGK Germany | 3 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.352 ml | 16.762 ml | 33.524 ml |
5 mM | 0.67 ml | 3.352 ml | 6.705 ml |
10 mM | 0.335 ml | 1.676 ml | 3.352 ml |
5 mM | 0.067 ml | 0.335 ml | 0.67 ml |
biological activity | AH 6809 is an antagonist of EP and DP receptors. the Ki values for cloned human EP1,EP2,EP3-III and DP receptors are 1217, 1150, 1597 and 1415 nM respectively, and the Ki values for mouse EP2 receptors are 350 nM. |
target | h-EP 1 receptor 1217 nM (Ki) h-EP 2 receptor 1150 nM (Ki) h-EP 3 -III receptor 1597 nM (Ki) m-EP 2 receptor 350 nM (Ki) hDP Receptor 1415 nM (Ki) |
in vitro study | AH 6809 (1 μM; 30 min) inhibits T. serrulatus venom (TsV)-induced and PGE 2 -amplified IL-1β and cAMP production in macrophages. AH 6809 (30-300 μM) antagonizes the anti-aggregatory activity of PGD2 in whole blood, with an apparent pA 2 of 5.35. |
in vivo study | AH 6809 (5 mg/kg; I. p.) decreases TsV-induced mortality, PGE 2 and IL-1β production and neutrophil infiltration in the lungs of mice. |